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Chronic disorders of consciousness (DOC) include the vegetative state
and the minimally consciousness state. The DOC diagnosis mainly relies
on the evaluation of clinical behavioral scales, electrophysiological
testing, and neuroimaging examinations. No specifically effective
neurorestorative methods for chronic DOC currently exist. Any valuable
exploration therapies of being able to repair functions and/or structures
in the consciousness loop (e.g., drugs, hyperbaric medicines, noninvasive
neurostimulation, sensory and environmental stimulation, invasive
neuromodulation therapy, and cell transplantation) may become
effective neurorestorative strategies for chronic DOC. In the viewpoint of
Neurorestoratology, this guideline proposes the diagnostic and
neurorestorative therapeutic suggestions and future exploration
direction for this disease following the review of the existing treatment
exploration achievements for chronic DOC.
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1

Overview

An intact ascending reticular activation system–
thalamus–cortex and cortex–cortex circuits are
necessary for normal consciousness. Patients
with a severe head injury and other critical
neurological diseases can be rescued with the
Corresponding author: YushengLi, E-mail: yushengli1970@163.com

development of emergency and intensive care
technology. However, coma becomes continuous
or disorders of consciousness (DOC) become
chronic because of the damaged structure and
function of the consciousness circuit. Chronic
DOC includes the vegetative state (VS) and the
minimally consciousness state (MCS).
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In the USA, about 300,000 adults and 120,000
children have chronic DOC [1]. Although the
accurate number of patients with chronic DOC
in China is still unavailable, it is conservatively
estimated to be about 100,000 new cases
annually, which is a huge challenge for clinical
medicine, especially for Neurorestoratology. The
management of DOC needs to be solved, which
is related to politics, economy, people’s
livelihood, and health in China. However,
following the nonstandardized procedures,
clinicians (even experienced clinicians) may
cause about 40% of diagnosis errors [2]. Huge
exploratory works have been done in
neuroimaging, neuroelectrophysiology, and
neurorestorative therapeutic technologies in
recent years with increasing attention and
cooperation for chronic DOC research by
scientists and doctors in various fields.
Consequently, great progress has been achieved
in chronic DOC diagnosis, prediction, and
treatment [2]. Those achievements and
knowledge are scattered in the different
disciplines in which the viewpoints for some of
them are different. The Chinese Association of
Neurorestoratology (Preparatory) and the
Chinese Committee of the International
Association of Neurorestoratology organized
professional experts to draw up the
recommendation guideline for the clinical
diagnosis and neurorestorative treatment for
chronic DOC based on these results. It aims to
promote standardized diagnosis and gradual
normalization of neurorestorative treatment for
this disease. This guideline will be periodically
updated with the exploration progress of
neurorestorative treatment.

2

Basic concepts

Consciousness is an individual's ability to
perceive the surrounding environment and own
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state. Consciousness has been described as a
combination of two components, i.e., arousal
and awareness. Arousal refers to the degree of
alertness or vigilance, whereas awareness refers
to the capacity to interact with the environment
or the self [3, 4].
Consciousness disorder is divided into
decreased arousal and change of conscious
content. Decreased arousal is characterized by
lethargy, comatose, and coma. Change of the
conscious content is characterized by confusion,
delirium, and special disturbances of consciousness including decortical syndrome, decerebral
rigidity, akinetic mutism, and VS [5].
VS characteristics. The patients’ self- and
environmental awareness disappear. In addition, no continuous, reproducible, purposeful,
or autonomous behavioral responses to
visual, auditory, tactile, or noxious stimuli
were noted. The ability of language
understanding or the expression disappears.
A sleep–wake cycle and autonomic neurological
function in the hypothalamus and brainstem
exist. Furthermore, urination and defecation
are incontinence, and the brain and spinal
cord reflexes are retained in varying degrees.
Its main clinical features are the loss of
self-expression and communication ability.
Moreover, patients with consciousness
disturbance of ≥ 28 days can be identified as
VS [6].
MCS characteristics. The patient is in an
awakened state with fluctuating and repeatable
conscious responses, i.e., having intermittent
and repeatable simple cognitive functions [7].
The clinical manifestations are being able to
respond to simple commands, being able to use
gestures or words to answer yes or no, and
speaking can be understood. Under special
environmental stimuli, patients show up with
temporary movement or emotional behaviors
without a relationship to reflexive activities (e.g.,

Journal of Neurorestoratology

52

patients may cry, smile, or laugh when
emotional, non-neutral topics, or stimuli are
expressed by verbal or visual form). Moreover,
patients directly respond to the talking content
of comments or questions, manifest as
pronouncing or gesturing, or reaching out to
fetch objects, wherein the position has a clear
relationship with the direction of fetching. In
addition, touching or holding the object enables
the contact mode to identify which fits the size
and shape of the object. Furthermore, patients
manifest as eye-tracking movement or
continuous gaze directly responding to a
movement or prominent stimuli [6].

3.2

Electrophysiological examination

Electroencephalogram. The electroencephalogram
(EEG) of patients with chronic DOC showed θ
wave (4–7.5 Hz) and/or δ wave (1–3.5 Hz)
frequency, including focal or diffuse continuous
Table 1 Coma Recovery Scale-Revised.
Score

Test

Auditory function scale
4

Consistent movement to command

3

Reproducible movement to command

2

Localization to sound

1

Auditory startle

0

None

Visual function scale

3

Diagnostic criteria

The diagnosis of chronic DOC relies on the
evaluation of clinical manifestation, electrophysiological testing, and neuroimaging examination.
3.1

5

Object recognition

4

Object localization: reaching

3

Visual pursuit

2

Fixation

1

Visual startle

0

None

Motor function scale

Clinical evaluation

6

Function object use

Medical history has a clear cause of chronic

5

Automatic motor response

consciousness

previous

4

Object manipulation

medications that affect consciousness. Moreover,

3

Localization to noxious stimulation

2

Flexion withdrawal

1

Abnormal posturing

0

None/flaccid

disorder,

excluding

records show the information of consciousness
disorder state in the routine physical and
neurological examinations. Furthermore, behavio-

Oral motor/verbal function scale

ral scales include Glasgow Coma Score, Coma

3

Intelligible verbalization

Recovery Scale-revised (CRS-R; Table 1), Wessex

2

Vocalization/oral movement

Head Injury Scale, and Complete Unrespons-

1

Oral reflexive movement

iveness Scale, Sensory Morphology Assessment

0

None

and Rehabilitation Skills Scale, Disorder of

Communication scale

Consciousness Scale, and Nociceptive Coma

2

Functional: accurate

Scale [5]. The CRS-R is the basic evaluation

1

Nonfunctional: intentional

0

None

index for chronic consciousness disorder, which
includes all MCS evaluation index scales [motor,

Arousal scale
3

Attention

visual, auditory, and/or cognitive impairment

2

Eye opening without stimulation

(e.g.,

1

Eye opening with stimulation

0

Unarousable

language,

attention)] [2, 6–9].

memory,

flexibility,

and
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slow waves, intermittent δ rhythm, weakened
EEG signal, and equipotential in severe cases
possibly appearing with γ wave, which is
related to slow-phase eye movements [10].
Brainstem auditory-evoked potential, visual evoked
potential, auditory brainstem-evoked response, and
somatosensory-evoked potential. The P100 in the
evoked potential is a sensitive indicator that
reflects the patient’s alleviation from VS.
Conversely, its absence indicates that the patient
is in VS. The P300 in the event-related evoked
potential can reflect the consciousness of
patients with chronic DOC. Furthermore, N400
mainly reflects the process related to language
processing, which has a certain value in judging
whether the patient is out of MCS. The
mismatch negative wave (MMN) means that
patients recover from cognitive disabilities.
Furthermore, > 1.5 μV is the reference value of
MMN wave amplitude in the MCS [11].

dorsolateral prefrontal cortex, and so on), and
indirectly evaluate the increase of cerebral
cortex blood flow. Moreover, the increase of
brain function metabolism indicates the
recovery of the disease.
Combined
multimodal
evaluation
can
effectively evaluate the state of patients with
impaired consciousness (VS and MCS), such as
positron emission tomography, resting-state
fMRI [9], functional magnetic resonance, or
active paradigm and quantitative analysis of the
high density of EEG [2]. In addition, transcranial
magnetic stimulation combined with electroencephalogram (TMS–EEG) has higher sensitivity
and specificity to differentiate VS.
The diagnosis of chronic DOC is mainly
evaluated by a well-trained clinician concerning
electrophysiological and neuroimaging examination information.

3.3

4

Neuroimaging examination

Routine head computed tomography and
magnetic resonance imaging (diffusion tensor
imaging, perfusion-weighted imaging, and
susceptibility-weighted imaging) examinations
can provide information of the whole structures
and damage degree to the patient’s brain
anatomy.
Resting-state fluorodeoxyglucose positron
emission tomography and functional magnetic
resonance imaging (fMRI) show the characteristics to define patients with VS and MCS [9], i.e.,
by comparing the response of the functional
area with normal people to judge whether the
patient has a consciousness activity.
Functional near-infrared spectrum technology
can measure the changes in the concentration of
oxygenated hemoglobin, deoxyhemoglobin, and
total hemoglobin, which are related to the
functional brain activity of the consciousnessrelated cortex (medial prefrontal cortex,

Clinical treatment

No specific neurorestorative therapeutic method
for chronic DOC currently exists, and any
restoring treatment for the consciousness loop
may become an effective treatment method [12].
Each patient should obtain personalized
comprehensive
neurorestorative
treatment
according to their specific condition. The
therapeutic principle is first to choose
noninvasive intervention and then invasive
intervention. The selection sequence for invasive
procedures goes from low to high risks.
4.1 Basic clinical management and treatment
[2, 12]
4.1.1 Nutrition management
Nutritional management involves giving
reasonable and abundant enteral nutrition;
maintaining the balance of hydroelectric
physiology, protein, fat, fiber, and so on; and
providing nutrition through nasogastric or

Journal of Neurorestoratology

54

nasointestinal tube or percutaneous gastrostomy
tube feeding for patients who cannot swallow.
4.1.2

Sphincter control

The sphincter is controlled by using a catheter,
external bag, or absorbent pad to avoid
complications of long-term indwelling catheterization; giving patients a balanced diet rich in
dietary fiber; and using lubricants for assisting
defecation to solve the problems of constipation
and anal incontinence.
4.1.3 Infection prevention
Infections are prevented by maintaining good
oral hygiene and preventing lung infections and
reducing the frequency of using catheters to
prevent urinary tract infections resulting in
kidney or blood system infections [2].
4.1.4 Drug therapy monitoring
Drug therapy monitoring is used to monitor
drugs that affect brain functions (e.g., epilepsy,
muscle spasm, increased muscle tone, and
abnormal bladder function). Spasticity is a
frequency complication with DOC disorders,
which may prevent the rehabilitation program.
Several complications have also been associated
with spasticity (e.g., muscle contracture, tendon
retraction, and fixed equinovarus foo), which
could further impede functional recovery,
increase the cost of treatment, and negatively
affect morbidity and mortality [2, 13].
4.1.5 Complication treatment
Treatment of complications aims to effectively
stabilize or control complications (e.g., diabetes,
heart, or lung diseases).
4.1.6 Prevention and treatment
complications for chronic DOC

of

primary

Hydrocephalus, bedsores, osteoporosis, pulmonary
embolism, and deep vein thrombosis in the
lower limbs are aimed for the prevention and

treatment of primary complications for chronic
DOC. Thus, specialty physician coverage should
be emphasized for the rapid management of
those complications including daily physician
rounds [1].
4.1.7 Maintaining sitting and standing positions
The best posture in sitting or standing is
maintained.
4.1.8 Muscle tension control and deformity prevention
This aims to reduce muscle tension and avoid
limb deformities or contractures. Muscle tension
control and deformity prevention are done by
preventing harmful irritation, maintaining a
well-supported position, taking oral antispasmodic drugs (e.g., baclofen), injecting botulinum
toxin into muscles, infusing baclofen through
intrathecal way, or transecting the spinal motor
nerve root [13–15].
4.2

Neurorestorative treatment

4.2.1 Drug therapy
Dopaminergic-like drugs (e.g., amantadine,
bromocriptine, and dopaserizide), glutamatergic-like drugs (e.g., zolpidem tartrate and
baclofen), cholinergic-like drugs (e.g., citicoline),
and Chinese medicine (e.g., Angong Niuhuang
Wan and Xingnaojing) are used for treatment.
Moreover, neurotrophic and vasodilator drugs
(e.g., neurotrophic factor, naloxone, niacin, and
ganglioside) are also used [16, 17].
Large studies have shown the positive
behavioral effects of amantadine in patients
with prolonged disorders of consciousness.
Amantadine has cerebral neurogenic antiinflammatory and anti-excitotoxic effects and
upregulates selective neurologic dopaminergic
pathway [18], which is recommended as a
conventional treatment drug (200 mg twice a
day) [2].
The intake of 10 mg of zolpidem shows
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behavioral improvement and transient functional recovery. In addition, some researchers
have found that receiving 20 or 30 mg of
zolpidem may induce stronger effects in
patients with disorders of consciousness [19].
Studies with EEG, fMRI, and PET have shown
an increased brain cortex activity and suggest
that the mechanisms of zolpidem’s response
may be by modulating the thalamic–cortical
network [20].
4.2.2 Hyperbaric oxygen (HBO2) therapy
One treatment course recommends 30 times.
Some studies provide strong proof for treating
severe brain injury with HBO2 therapy, which
could improve physiologic function without
fewer side-effects [21]. The neuroprotective
effect of HBO2 therapy includes reduced lesion
size, brain water content, and apoptosis through
an anti-inflammatory mechanism [22].
4.2.3 Neurostimulation therapy
Right median nerve electrical stimulation. The
electrode is placed at the median nerve point of
patients, which is 2 cm above the ventral carpal
stria. The right nerve for electrical stimulation
with direct current stimulation, current intensity
(10–20 mA), frequency (40–70 Hz), 1 time/day
(30 min/time to 8 h/time for 7–30 days), is
generally chosen [23].
Repetitive transcranial magnetic stimulation. The
stimulation intensity, total number of stimulations, and treatment course are 90–100% MT,
300–1,500 pulses, and 1–20 days, respectively, to
use 5–20 Hz TMS to stimulate the dorsolateral
prefrontal cortex (DLPFC) or M1 area in the
dorsolateral prefrontal lobe [6, 24–27]. However,
TMS therapy is not recommended for patients
with a history of epilepsy or metal implants in
their bodies.
Transcranial direct current stimulation [28–36].
DLPFC or posterior parietal cortex at 10–20
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min/time (1–2 mA for 10–20 days) was chosen.
The treatment precautions are similar to rTMS.
Transcutaneous electrical stimulation to the ear
branch of the vagus nerve. This procedure
stimulates the autonomic nerve of the ear to
regulate the function of the vagus nerve, which
is based on superficial branches of this nerve
and the acupuncture principle of traditional
Chinese medicine (20 min/time, 1 mA, and 4–8
weeks) [37–40].
The mesocircuit frontoparietal model for
mechanisms underlying the eﬀects of interventions in severe brain injuries may explain the
potential mechanisms of various therapeutic
interventions and the neural mechanisms of
impaired consciousness [41].
4.2.4 Sensory and environmental stimulation therapy
The sensory and environmental stimulation
therapy is according to the patients’ habits,
hobbies, and working conditions to design and
give patients’ favorable or unfavorable sounds,
colors, smells, touch, taste, and other auditory,
visual, tactile, olfactory, taste and oral, and more
sensory stimulations [42–44].
4.2.5 Neurorehabilitation
Verticalization is beneficial to patients in DOC in
early rehabilitation. Interventions involved ten
1-h sessions of this specific treatment over 3
weeks [45].
4.2.6 Acupuncture combined with Chinese herbal
medicine
Xing Nao Kai Qiao acupuncture combined with
Angong Niuhuang and Xingnaojing significantly improved consciousness for a patient
with VS after a 50-day treatment [46].
4.2.7 Invasive neuromodulation therapy
Spinal cord stimulation. This is done by placing
stimulating electrodes on the epidural on
the dorsal cervical sites 2–4 with voltage (2–5 V),
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which corresponds to the frontal cortex,
stimulation voltage (3.5–7.0 V), pulse width
(210–300 μs), frequency (30–50 Hz), stimulation
time (30 min), and interval (30 min) [57].
Baclofen pump implantation (intrathecal baclofen).
The low blood–brain barrier permeability of
baclofen, which is pumped into the intrathecal
site of the lumbar spine, can significantly
increase drug concentration in the central
nervous system and improve the therapeutic
effect in both consciousness and spasticity. The
maximum daily dose is 1,000 μg. Moreover, it
can be adjusted from 2 to 3 μg/h according to
the clinical manifestation of the patient [58].
4.2.8 Cell therapy
Fig. 1 Consciousness disorder treatment process.

stimulation frequency (5 or 70 Hz), and working
time (12 h in one day). Moreover, 70 Hz and
100–240 μs are recommended as the priority
stimulation frequency and the pulse width,
respectively [47–49].
Deep-brain stimulation (DBS). The unipolar
stimulation is the main DBS function to place
the stimulating electrode on the central nucleus
with a stimulation frequency (25–100 Hz), wave
width (100–240 μs), and voltage (1–4.0 V). The
accuracy of DBS implantation cannot be
guaranteed when the thalamus in one side is
severely damaged or the third ventricle and
thalamus are significantly displaced owing to
obvious brain atrophy. Thus, DBS surgery
should be carefully selected [5, 50–55].
Vagus nerve stimulation. This is done by
placing the electrode on the vagus nerve trunk
in the neck to increase to the maximum intensity
(1.0–1.5 mA) [56], pulse width (500 μν),
frequency (25–30 Hz), stimulation time (30 s),
interval (5 min), and conduct the regulation
according to the response.
Extradural cortical stimulation. This is done by
placing the electrodes on the epidural site,

Cell therapy is promising for neurological
diseases including DOC [59]. However, many
questions need to be answered for clinical
application (e.g., cell type, cell dosage,
transplanted route, and therapeutic time
window). Moreover, olfactory ensheathing cells
were implanted into the key points of the neural
network repair on both sides. Cell dosage is 1
million per side [60]. Furthermore, autologous
bone marrow mesenchymal stromal cells (5 × 106)
were injected through the intrathecal way by
lumbar puncture [61].
Both of these two kinds of cells showed some
help in recovering consciousness. These two
kinds of cell preparation currently follow the
standardization of cell culture [62, 63].
5 Limitation and prospective direction
Neurorestorative treatments for chronic DOC
are still currently in the stage of clinical
exploration. The majority is not conventional or
routine therapeutic strategies. Although some
treatments have been shown helpful in
recovering consciousness, strong support from
higher-level evidence-based medicine of clinical
trials is not obtained. Exploring key effective
factors for each patient and giving personalized
Journal of Neurorestoratology
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precision therapy is necessary for clinical
practice.
Cell
therapy,
neurostimulation/
neuromodulation, and so on, which have shown
some effects in clinical practice, should be
explored with higher-level evidence-based
medical clinical trials in the future to prove their
neurorestorative effects for chronic DOC.
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